Scholars Central

EditorialPublished 31 Jul 2023

A Comprehensive Review of Direct Acting Antivirals in Chronic Viral Hepatitis Therapy

Authors: Bithonah Prasad

Department of Thoracic Surgery and Tumors, Oncology Centre of Bydgoszcz, Bydgoszcz, Poland

Journal of Clinical Infectious Diseases & Practice

Volume 8 · Issue 4 · Pages 1–3

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Chronic viral hepatitis is a global public health concern affecting millions of people worldwide. Traditional treatment options for chronic viral hepatitis, including interferon-based therapies, often had limited efficacy and significant side effects. However, the advent of direct acting antivirals (DAAs) has revolutionized the management of chronic viral hepatitis. In this comprehensive review, we provide an overview of the classes of DAAs available for the treatment of chronic hepatitis B and C, highlighting their mechanisms of action, clinical efficacy, safety profiles, and impact on viral clearance. Additionally, we discuss the challenges and future prospects of DAA therapy, emphasizing the potential for achieving sustained virologic responses and eventually eradicating chronic viral hepatitis.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

More from this journal

The newest in Journal of Clinical Infectious Diseases & Practice.

All its articles

Conferences in this field

Upcoming conferences in this field.

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalJournal of Clinical Infectious Diseases & Practice
  • SubjectInfectious Diseases
  • BylineArticles whose byline prints “Bithonah Prasad”